Download FREE Report Sample
Download Free sampleNitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Medical Inhaled Nitric Oxide Market contains market size and forecasts of Medical Inhaled Nitric Oxide in global, including the following market information:
Global Medical Inhaled Nitric Oxide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Inhaled Nitric Oxide Market Sales, 2017-2022, 2023-2028, (M L)
Global top five Medical Inhaled Nitric Oxide companies in 2021 (%)
The global Medical Inhaled Nitric Oxide market was valued at 1077.4 million in 2021 and is projected to reach US$ 1921.1 million by 2028, at a CAGR of 8.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
800 ppm Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Inhaled Nitric Oxide include Mallinckrodt, Linde and Air Liquide, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Inhaled Nitric Oxide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Inhaled Nitric Oxide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M L)
Global Medical Inhaled Nitric Oxide Market Segment Percentages, by Type, 2021 (%)
Global Medical Inhaled Nitric Oxide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M L)
Global Medical Inhaled Nitric Oxide Market Segment Percentages, by Application, 2021 (%)
Global Medical Inhaled Nitric Oxide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M L)
Global Medical Inhaled Nitric Oxide Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy